Post-marketing Pharmacovigilance and Medical Information Market Size & Forecast By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Product (Books, Online Media, Journals), By End-use (Hospitals, Research organization) And Trend Analysis From 2012 - 2022

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Country wise market calculation
                   1.2 Region based segment share calculation
                   1.3 Primary Sources
                   1.4 List of secondary sources
                   1.5 Scope of study
Chapter 2 Executive Summary
Chapter 3 Post-Marketing Pharmacovigilance Industry Outlook
                   3.1 Market segmentation
                   3.2 Market size and growth prospects, 2012 - 2022
                   3.3 Pharmacovigilance: Market dynamics
                      3.3.1 Market driver analysis
                           3.3.1.1 Growing drug consumption and drug development rates
                           3.3.1.2 Increasing incidence rates of ADR and drug toxicity
                           3.3.1.3 Increasing trend of outsourcing pharmacovigilance services
                      3.3.2 Market restraint analysis
                           3.3.2.1 Lack of skilled labor
                           3.3.2.2 Stringent regulatory framework
                   3.4 Key opportunities analysis, 2014
                   3.5 Pharmacovigilance Competitive Landscape, 2014
                      3.5.1 Competitive Landscape: Market Position Analysis
                   3.6 Industry analysis - Porter’s
                   3.7 Pharmacovigilance- PESTEL analysis
                   3.8 Ansoff Matrix
                   3.9 Pharmacovigilance Post Marketing Country Wise Implementation
Chapter 4 Post-marketing Pharmacovigilance Type Outlook
                   4.1 Post-marketing pharmacovigilance market share, by type, 2014 & 2022
                   4.2 Spontaneous reporting
                      4.2.1 Spontaneous reporting market, 2012 - 2022 (USD Million)
                   4.3 Intensified ADR Reporting
                      4.3.1 Intensified ADR reporting market, 2012 - 2022 (USD Million)
                   4.4 Targeted Spontaneous Reporting
                      4.4.1 Targeted spontaneous reporting market, 2012 - 2022 (USD Million)
                   4.5 Cohort Event Monitoring
                      4.5.1 Cohort event monitoring market, 2012 - 2022 (USD Million)
                   4.6 EHR Mining
                      4.6.1 EHR mining market, 2012 - 2022 (USD Million)
Chapter 5 Post-Marketing Pharmacovigilance And Medical Information Product Outlook
                   5.1 Post-marketing pharmacovigilance and medical information market share, by product, 2014 & 2022
                   5.2 Books
                      5.2.1 Books market, 2012 - 2022 (USD Million)
                   5.3 Online media
                      5.3.1 Online media market, 2012 - 2022 (USD Million)
                   5.4 Journals
                      5.4.1 Journals market, 2012 - 2022 (USD Million)
Chapter 6 Post-Marketing Pharmacovigilance And Medical Information End-use Outlook
                   6.1 Global post-marketing pharmacovigilance and medical information market share, by end-use, 2014 & 2022
                   6.2 Hospitals
                      6.2.1 Hospitals market, 2012 - 2022 (USD Million)
                   6.3 Research organizations
                      6.3.1 Research organizations market, 2012 - 2022 (USD Million)
                   6.4 Others
                      6.4.1 Others market, 2012 - 2022 (USD Million)
Chapter 7 Post-Marketing Pharmacovigilance and Medical Information Regional Outlook
                   7.1 Post-marketing pharmacovigilance and medical information market share, by region, 2014 & 2022
                   7.2 North America
                      7.2.1 North America pharmacovigilance(post-marketing) market, 2012 - 2022 (USD Million)
                      7.2.2 U.S.
                           7.2.2.1 U.S. post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.2.3 Canada
                           7.2.3.1 Canada post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                   7.3 Europe
                      7.3.1 Europe post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.3.2 UK
                           7.3.2.1 UK post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.3.3 Germany
                           7.3.3.1 Germany post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.3.4 France
                           7.3.4.1 Francepost-marketing pharmacovigilancemarket, 2012 - 2022 (USD Million)
                   7.4 Asia Pacific
                      7.4.1 Asia Pacific post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.4.2 Japan
                           7.4.2.1 Japan post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.4.3 China
                           7.4.3.1 China post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.4.4 India
                           7.4.4.1 India post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                   7.5 Latin America
                      7.5.1 Latin America pharmacovigilance(post-marketing) market, 2012 - 2022 (USD Million)
                      7.5.2 Brazil
                           7.5.2.1 Brazil post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.5.3 Mexico
                           7.5.3.1 Mexico post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                   7.6 MEA
                      7.6.1 MEA post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
                      7.6.2 South Africa
                           7.6.2.1 South Africa post-marketing pharmacovigilancemarket, 2012 - 2022 (USD Million)
Chapter 8 Competitive Landscape
                   8.1 Accenture Plc.
                      8.1.1 Company Overview
                      8.1.2 Financial Performance
                      8.1.3 Platform Benchmarking
                      8.1.4 Strategic Initiatives
                   8.2 Clinquest Group B.V.
                      8.2.1 Company Overview
                      8.2.2 Financial Performance
                      8.2.3 Platform Benchmarking
                      8.2.4 Strategic Initiatives
                   8.3 Cognizant Technology Solutions Corporation
                      8.3.1 Company Overview
                      8.3.2 Financial Performance
                      8.3.3 Product Benchmarking
                      8.3.4 Strategic Initiatives
                   8.4 Covance Inc.
                      8.4.1 Company Overview
                      8.4.2 Financial Performance
                      8.4.3 Product Benchmarking
                      8.4.4 Strategic Initiatives
                   8.5 iMEDGlobal Corporation
                      8.5.1 Company Overview
                      8.5.2 Financial Performance
                      8.5.3 Product Benchmarking
                      8.5.4 Strategic Initiatives
                   8.6 inVentiv Health Clinical
                      8.6.1 Company Overview
                      8.6.2 Financial Performance
                      8.6.3 Product Benchmarking
                      8.6.4 Strategic Initiatives
                   8.7 Parexel International Corporation
                      8.7.1 Company Overview
                      8.7.2 Financial Performance
                      8.7.3 Product Benchmarking
                      8.7.4 Strategic Initiatives
                   8.8 Pharmaceutical Product Development, Inc. (PPD, Inc.)
                      8.8.1 Company Overview
                      8.8.2 Financial Performance
                      8.8.3 Product Benchmarking
                      8.8.4 Strategic Initiatives
                   8.9 PRA Health Sciences Inc.
                      8.9.1 Company Overview
                      8.9.2 Financial Performance
                      8.9.3 Product Benchmarking.
                      8.9.4 Strategic Initiatives
                   8.10 Quintiles
                      8.10.1 Company Overview
                      8.10.2 .Financial Performance
                      8.10.3 Product Benchmarking
                      8.10.4 Strategic Initiatives
                   8.11 F. Hoffmann-La Roche Ltd.
                      8.11.1 Company Overview
                      8.11.2 Financial Performance
                      8.11.3 Product Benchmarking
                      8.11.4 Strategic Initiatives
                   8.12 Sanofi Aventis
                      8.12.1 Company Overview
                      8.12.2 Financial Performance
                      8.12.3 Product Benchmarking.
                      8.12.4 Strategic Initiatives
                   8.13 Synowledge LLC
                      8.13.1 Company Overview
                      8.13.2 Financial Performance
                      8.13.3 Product Benchmarking.
                      8.13.4 Strategic Initiatives
                   8.14 Wipro Ltd.
                      8.14.1 Company Overview
                      8.14.2 Financial Performance
                      8.14.3 Product Benchmarking.
                      8.14.4 Strategic Initiatives
                   8.15 ArisGlobal
                      8.15.1 Company Overview
                      8.15.2 Financial Performance
                      8.15.3 Product Benchmarking
                      8.15.4 Strategic Initiatives
                   8.16 Ergomed Plc
                      8.16.1 Company Overview
                      8.16.2 Financial Performance
                      8.16.3 Product Benchmarking.
                      8.16.4 Strategic Initiatives

List of Tables

TABLE 1 Post-marketing pharmacovigilance - Industry Snapshot & Key Buying Criteria, 2012 - 2022
TABLE 2 Global pharmacovigilance (post-marketing) market, by type, 2012 - 2022(USD Million)
TABLE 3 Global pharmacovigilance (post marketing) and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 4 Global post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 5 Global post-marketing pharmacovigilance market, by region, 2012 - 2022 (USD Million)
TABLE 6 Pharmacovigilance - Key market driver analysis
TABLE 7 List of notable drug withdrawals due to ADRs
TABLE 8 Pharmacovigilance - Key market restraint analysis
TABLE 9 Pharmacovigilance - Post marketing country-wise implementation
TABLE 10 North America post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 11 North America post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 12 North America post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 13 U.S. post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 14 U.S. post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 15 U.S. post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 16 Canada post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 17 Canada post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 18 Canada post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 19 Europe pharmacovigilance(post-marketing) market, by type, 2012 - 2022 (USD Million)
TABLE 20 Europe pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 21 Europe pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 22 UK post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 23 UK post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 24 UK post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 25 Germany post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 26 Germany post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 27 Germany post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 28 France post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 29 France post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 30 France post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 31 Asia Pacific post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 32 Asia Pacific post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 33 Asia Pacific post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 34 Japan post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 35 Japan post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 36 Japan post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 37 China pharmacovigilance(post-marketing) market, by type, 2012 - 2022 (USD Million)
TABLE 38 China post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 39 China post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 40 India Post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 41 India post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 42 India post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 43 Latin America post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 44 Latin America post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 45 Latin America post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 46 Brazil post-marketing pharmacovigilance market, by type, 2012 - 2022 (USD Million)
TABLE 47 Brazil post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 48 Brazil post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 49 Mexico post-marketing pharmacovigilance and medical information market, by type, 2012 - 2022 (USD Million)
TABLE 50 Mexico post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 51 Mexico post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 52 MEA post-marketing pharmacovigilance market, by product, 2012 - 2022 (USD Million)
TABLE 53 MEA post-marketing pharmacovigilance and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 54 MEA post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)
TABLE 55 South Africa pharmacovigilance(post-marketing) market, by product, 2012 - 2022 (USD Million)
TABLE 56 South Africa pharmacovigilance(post-marketing) and medical information market, by product, 2012 - 2022 (USD Million)
TABLE 57 South Africa post-marketing pharmacovigilance and medical information market, by end-use, 2012 - 2022 (USD Million)

List of Figures

FIG. 1 Post MarketingPharmacovigilance: Market segmentation
FIG. 2 Global post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 3 Pharmacovigilance: Market dynamics
FIG. 4 Key opportunities prioritized, 2014
FIG. 5 Competitive Landscape Analysis, 2014
FIG. 6 Pharmacovigilance market – Porter’s analysis
FIG. 7 Pharmacovigilance market – PESTEL analysis
FIG. 8 Pharmacovigilance Ansoff Matrix, 2014
FIG. 9 Post-marketing pharmacovigilance revenue share, by type, 2014 & 2022
FIG. 10 Spontaneous reporting market, 2012 - 2022 (USD Million)
FIG. 11 Intensified ADR reporting market, 2012 - 2022 (USD Million)
FIG. 12 Targeted spontaneous reporting market, 2012 - 2022 (USD Million)
FIG. 13 Cohort event monitoring market, 2012 - 2022 (USD Million)
FIG. 14 EHR mining market, 2012 - 2022 (USD Million)
FIG. 15 Post-marketing pharmacovigilance and medical information revenue share, by product, 2014 & 2022
FIG. 16 Books market, 2012 - 2022 (USD Million)
FIG. 17 Online media market, 2012 - 2022 (USD Million)
FIG. 18 Journals market, 2012 - 2022 (USD Million)
FIG. 19 Pharmacovigilance(post-marketing) and medical information revenue share, by end-use, 2014 & 2022
FIG. 20 Hospitals market, 2012 - 2022 (USD Million)
FIG. 21 Research organizations market, 2012 - 2022 (USD Million)
FIG. 22 Others market, 2012 - 2022 (USD Million)
FIG. 23 Post-marketing pharmacovigilance and medical information market share, by region, 2014 & 2022
FIG. 24 North America pharmacovigilance(post-marketing) market, 2012 - 2022 (USD Million)
FIG. 25 U.S. post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 26 Canada post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 27 Europe post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 28 UK post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 29 Germany pharmacovigilance(post-marketing) market, 2012 - 2022 (USD Million)
FIG. 30 France post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 31 Asia Pacific post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 32 Japan post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 33 China post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 34 India post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 35 Latin America pharmacovigilance(post-marketing) market, 2012 - 2022 (USD Million)
FIG. 36 Brazil post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 37 Mexico post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 38 MEA post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)
FIG. 39 South Africa post-marketing pharmacovigilance market, 2012 - 2022 (USD Million)